During the last session, Eledon Pharmaceuticals Inc (NASDAQ:ELDN)’s traded shares were 0.41 million, with the beta value of the company hitting 0.77. At the end of the trading day, the stock’s price was $4.38, reflecting an intraday loss of -0.45% or -$0.02. The 52-week high for the ELDN share is $5.54, that puts it down -26.48 from that peak though still a striking 69.41% gain since the share price plummeted to a 52-week low of $1.34. The company’s market capitalization is $261.66M, and the average intraday trading volume over the past 10 days was 0.53 million shares, and the average trade volume was 447.96K shares over the past three months.
Eledon Pharmaceuticals Inc (ELDN) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. ELDN has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.34.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Eledon Pharmaceuticals Inc (NASDAQ:ELDN) trade information
Eledon Pharmaceuticals Inc (ELDN) registered a -0.45% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -0.45% in intraday trading to $4.38, hitting a weekly high. The stock’s 5-day price performance is -4.78%, and it has moved by 2.58% in 30 days. Based on these gigs, the overall price performance for the year is 212.86%. The short interest in Eledon Pharmaceuticals Inc (NASDAQ:ELDN) is 0.69 million shares and it means that shorts have 0.75 day(s) to cover.
Eledon Pharmaceuticals Inc (ELDN) estimates and forecasts
Statistics show that Eledon Pharmaceuticals Inc has outperformed its competitors in share price, compared to the industry in which it operates. Eledon Pharmaceuticals Inc (ELDN) shares have gone up 44.55% during the last six months, with a year-to-date growth rate more than the industry average at 61.59% against 17.10.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 29.97%. While earnings are projected to return 51.83% in 2024.
ELDN Dividends
Eledon Pharmaceuticals Inc is due to release its next quarterly earnings in January. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 2.34 million shares, is of ARMISTICE CAPITAL, LLC’s that is approximately 7.7894% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $6.17 million.
